Exxon eyes return to Iraq to explore Majnoon oil field, Bloomberg News reports-March 2024-www.financetom.com

Exxon eyes return to Iraq to explore Majnoon oil field, Bloomberg News reports

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Exxon eyes return to Iraq to explore Majnoon oil field, Bloomberg News reports

Oct 7, 2025 4:15 PM

Oct 7 (Reuters) - Oil major Exxon Mobil ( XOM ) is

considering re-entering Iraq after a nearly two-year hiatus by

signing agreements that would lay the groundwork to explore the

country's giant Majnoon field, Bloomberg News reported on

Tuesday, citing people familiar with the matter.

Reuters could not immediately verify the report.

Previous page： NV5 Global Names Ben Heraud CEO Next page： Adobe Says US Online Spending Hit Record $241.4 Billion in 2024 Holiday Season

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

NV5 Global Names Ben Heraud CEO

Jan 7, 2025

08:59 AM EST, 01/07/2025 (MT Newswires) -- NV5 Global ( NVEE ) said Tuesday it has named Ben Heraud the company's chief executive officer. Heraud has been the chief operating officer of NV5's buildings and technology group since 2020, the company said. NV5 also said that its Founder Dickerson Wright will continue indefinitely in his role as executive chair. The...

Adobe Says US Online Spending Hit Record $241.4 Billion in 2024 Holiday Season

Jan 7, 2025

09:03 AM EST, 01/07/2025 (MT Newswires) -- Adobe (ADBE) said Tuesday that US consumers spent a record $241.4 billion online from November 1 to December 31, marking an 8.7% increase year-over-year. The company said the season saw 15 days where consumers spent over $4 billion in a single day, up from 11 days in 2023. It added that mobile shopping...

Immuneering Says New Phase 2a Pancreatic Cancer Trial Data Show Better Response, Disease Control Rates

Jan 7, 2025

09:00 AM EST, 01/07/2025 (MT Newswires) -- Immuneering ( IMRX ) said Tuesday that new data from an ongoing phase 2a trial of its lead candidate IMM-1-104 in pancreatic cancer showed better overall response and disease control rates. The updated results for IMM-1-104 combined with modified gemcitabine/nab-paclitaxel showed pancreatic cancer patients achieved an overall response rate of 43% and a...

AI startups drive VC funding resurgence, capturing record US investment in 2024

Jan 7, 2025

Jan 7 (Reuters) - Artificial intelligence startups have contributed significantly to the recovery of U.S. venture capital funding from market lows, with the total capital raised in 2024 nearly 30% higher year-on-year, according to PitchBook data released on Tuesday. AI startups also captured a record 46.4% of the total $209 billion raised last year, compared to less than 10% a...